Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
Alzheimer's disease (AD) is a progressive neurological condition characterized by cognitive decline, memory loss, and aberrant behaviour. It affects millions of people globally and is one of the main causes of dementia. The neurodegenerative condition known as AD has intricate, multifaceted mechanisms that make it difficult to comprehend and identify in its early stages. Conventional diagnostic te...
Proteins are inherently dynamic, and their conformational ensembles play a crucial role in biological function. Large-scale motions may govern the protein structure-function relationship, and numerous transient but stable conformations of intrinsically disordered proteins (IDPs) can play a crucial role in biological function. Investigating conformational ensembles to understand regulations and dis...
Butyrylcholinesterase inhibition offers one of the formulated solutions to tackle the aggravating symptoms of dementia that downgrades to cholinergic ...
Convolutional neural networks (CNNs) and mammalian visual systems share architectural and information processing similarities. We leverage these paral...
We introduce HARMONI, a three-dimensional (3D) computer vision and audio processing method for analyzing caregiver-child behavior and interaction from...
BACKGROUND: Since its emergence in 2019, COVID-19 has become a global epidemic. Several studies have suggested a link between Alzheimer's disease (AD)...
Alzheimer's Disease (AD) is a progressive condition of a neurological brain disorder recognized by symptoms such as dementia, memory loss, alterations...
Recently, deep learning-based medical image classification models have made substantial advancements. However, many existing models prioritize perform...
Digital health innovations hold diagnostic and therapeutic promise but may be subject to biases for underrepresented groups. We explored perceptions o...
The development of BACE-1 (β-site amyloid precursor protein cleaving enzyme 1) inhibitors is a crucial focus in exploring early treatments for Alzheim...
While multi-modal deep learning approaches trained using magnetic resonance imaging (MRI) and fluorodeoxyglucose positron emission tomography (FDG PET...
Approximately 50% of Alzheimer's disease (AD) patients develop psychotic symptoms, leading to a subtype known as psychosis in AD (AD + P), which is as...
Alzheimer's disease (AD) is a leading cause of disability worldwide. Early detection is critical for preventing progression and formulating effective ...
Alzheimer's Disease (AD) is a significant cause of mortality in elderly people. The diagnosing and classification of AD using conventional manual oper...
Deep learning (DL) for predicting Alzheimer's disease (AD) has provided timely intervention in disease progression yet still demands attentive interpr...
BACKGROUND: Early diagnosis and accurate prognosis of cognitive decline in Alzheimer's disease (AD) is important to timely assignment to optimal treat...
Alzheimer's disease (AD) is a degenerative neurological condition characterized by a progressive decline in cognitive abilities, resulting in memory i...
Alzheimer's disease (AD) is a type of brain disorder that is becoming more prevalent worldwide. It is a progressive and irreversible condition that gr...
BACKGROUND AND OBJECTIVE: Deep learning models have gained widespread adoption in healthcare for accurate diagnosis through the analysis of brain sign...
OBJECTIVES: Alzheimer's disease (AD) poses a significant challenge for individuals aged 65 and older, being the most prevalent form of dementia. Altho...